Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Donna Vermes, MS, NPP
JCP
Letter to the Editor
Memantine in OCD
May 25, 2016
Ketamine may reduce OCD symptoms in some patients, but IV administration is undesirable. Learn whether oral memantine, another NMDA receptor antagonist, would be a good alternative.
Carolyn I. Rodriguez
,
Amanda Levinson
,
Jordana Zwerling
, et al
JCP
Original Research
Six-Month Outcomes From a Randomized Trial Augmenting Serotonin Reuptake Inhibitors With Exposure and Response Prevention or Risperidone in Adults With Obsessive-Compulsive Disorder
April 22, 2015
Edna B. Foa
,
Helen Blair Simpson
,
David Rosenfield
, et al
JCP
Article
Probability and Predictors of First Treatment Contact for Anxiety Disorders in the United States: Analysis of Data From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
November 15, 2013
Miren Iza
,
Mark Olfson
,
Donna Vermes
, et al
JCP
Original Research
Six-Month Follow-Up of a Randomized Controlled Trial Augmenting Serotonin Reuptake Inhibitor Treatment With Exposure and Ritual Prevention for Obsessive-Compulsive Disorder
May 15, 2013
Edna B. Foa
,
Helen Blair Simpson
,
Michael R. Liebowitz
, et al